trending Market Intelligence /marketintelligence/en/news-insights/trending/1teZv6xCdrF_v6uN7Aqsqg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Albireo Pharma plans $50M offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Albireo Pharma plans $50M offering

Albireo Pharma, Inc. said it plans to sell common stock having an aggregate offering price of up to $50 million.

Cowen and Co. LLC will act as the company's sales agent.